Below are a few frequently asked questions that explain the key benefits of the HealSmart™ Personalized Woundcare System.

Q. What is HealSmart?

A. HealSmart is a personalized woundcare system that helps optimize clinical and economic woundcare outcomes. Tools and training are provided to drive consistency and reduce variability around woundcare assessment, dressing selection, and visibility of healing progress.

Based on standardized assessment data, HealSmart’s woundcare matrix recommends a personalized dressing with the appropriate size, shape, and level of absorption, hydration, and moisture vapor transfer rate as needed, specific to the wound. As the wound progresses, the dressing configuration changes to meet the healing needs of the wound.

Analytics are also provided to view the healing trajectory of each patient over time. Your agency gets objective information for effective dialogue with physicians and patients throughout the healing progression.

Q. What are the HealSmart dressings made of?

A. HealSmart Personalized Dressings are made from 2 types of microfiber polymers: hydrophilic (absorbing) and hydrophobic (moisture repelling). Patented microfiber technology adapts to create dressings that are absorbent or hydrating, as specified.

HealSmart Dressings contain polyhexamethylene biguanide (PHMB), an antimicrobial that protects healing cells from bacterial proliferation in the dressing.

HealSmart Dressings contain Hyaluronic Acid (HA), a naturally occurring solution in the body known to assist in wound healing.

Q. What is the evidence that these dressings work?

A. HealSmart Personalized Dressings are FDA cleared and have been clinically evaluated in over 12,000 placements with a 96% satisfaction rate due to personalized treatment. Several clinical studies have demonstrated improvements in wound area reduction and the reduction in the number of stalled wounds with the use of HealSmart Personalized Dressings.1

In the most recent 2012 study, chronic wounds in home care treated with HealSmart dressings over a 120-day period demonstrated1

  • Increased median wound area reduction (86% vs 72%)
  • More healed wounds (44% vs 33%)
  • Fewer stalled or deteriorating wounds (18% vs 28%)


  1. PolyRemedy clinical research. Details can be accessed at